No chemopreventive effect of nonsteroidal anti-inflammatory drugs on nonmelanoma skin cancer: Evidence from meta-analysis

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Zhang, Bo ^a,b   Liang, Xiaolu ^b   Ye, Liaosha ^b   Wang, Yungui ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; NONSTEROID ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT;

ARTICLE; BASAL CELL CARCINOMA; CANCER PREVENTION; CLINICAL EVALUATION; DRUG EFFICACY; EVIDENCE BASED MEDICINE; HUMAN; META ANALYSIS; NON MELANOMA SKIN CANCER; OUTCOME ASSESSMENT; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SQUAMOUS CELL CARCINOMA; SYSTEMATIC REVIEW; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; PATHOLOGY; PROSPECTIVE STUDY; RISK FACTOR; SKIN NEOPLASMS; TREATMENT FAILURE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICARCINOGENIC AGENTS; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; HUMANS; PROSPECTIVE STUDIES; RISK FACTORS; SKIN NEOPLASMS; TREATMENT FAILURE;

EID: 84901361960     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096887     Document Type: Article

References (24)

1. Lomas A, Leonardi-Bee J, Bath-Hextall (2012) A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 166(5):1069-1080.
2. Patel RV, Frankel A, Goldenberg G (2011) An update on nonmelanoma skin cancer. J Clin Aesthet Dermatol 4(2):20-27.
3. Ohtsuka H (2011) Statistical Survey of Deaths from Nonmelanoma Skin Cancer in Japan during 54 Years. J Skin Cancer 2011:293926.
4. Einspahr JG, Bowden GT, Alberts DS (2003) Skin cancer chemoprevention: strategies to save our skin. Recent Results Cancer Res 163:151-164; discussion 264-156.
5. Einspahr JG, Stratton SP, Bowden GT, Alberts DS (2002) Chemoprevention of human skin cancer. Crit Rev Oncol Hematol 41(3):269-285. (Pubitemid 34203664)
6. Diepgen TL, Fartasch M, Drexler H, Schmitt J (2012)Occupational skin cancer induced by ultraviolet radiation and its prevention. Br J Dermatol 167 Suppl 2:76-84.
7. Peyrin-Biroulet L, Khosrotehrani K, Carrat F, Bouvier AM, Chevaux JB, et al (2011) Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease. Gastroenterology 141(5):1621-1628 e1621-1625.
8. Wang WH, Huang JQ, Zheng GF, Lam SK, Karlberg J, et al (2003) Nonsteroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis. J Natl Cancer Inst 95(23):1784-1791. (Pubitemid 38008901)
9. Algra AM, Rothwell PM (2012) Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol 13(5):518-527.
10. McCaffrey P (2006) Aspirin use reduces skin-cancer risk. Lancet Oncol 7(1):16.
11. Rothwell PM, Wilson M, Price JF, Belch JF, Meade TW, et al (2012) Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials. Lancet 379(9826):1591-1601.
12. Sun L, Yu S (2011) Meta-analysis: non-steroidal anti-inflammatory drug use and the risk of esophageal squamous cell carcinoma. Dis Esophagus 24(8):544-549.
13. Huang C, Ma WY, Hanenberger D, Cleary MP, Bowden GT, et al (1997): Inhibition of ultraviolet B-induced activator protein-1 (AP-1) activity by aspirin in AP-1-luciferase transgenic mice. J Biol Chem 272(42):26325-26331. (Pubitemid 27458846)
14. Marks F, Furstenberger G, Neufang G, Muller-Decker K (2003) Mouse skin as a model for cancer chemoprevention by nonsteroidal anti-inflammatory drugs. Recent Results Cancer Res 163:46-57; discussion 264-266.
15. Johannesdottir SA, Chang ET, Mehnert F, Schmidt M, Olesen AB, et al (2012) Nonsteroidal anti-inflammatory drugs and the risk of skin cancer: A populationbased case-control study. Cancer 118(19):4768-4776.
16. Asgari MM, Chren MM, Warton EM, Friedman GD, White E (2010)Associ- Association between nonsteroidal anti-inflammatory drug use and cutaneous squamous cell carcinoma. Arch Dermatol 146(4):388-395.
17. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003)Measuring inconsistency in meta-analyses. BMJ 327(7414):557-560. (Pubitemid 37088507)
18. Borenstein M HL, Higgins JPT, Rothstein H (2009) Introduction to metaanalysis. United Kingdom: John Wiley & Sons, Ltd.
19. Jeter JM, Han J, Martinez ME, Alberts DS, Qureshi AA, et al (2012) Nonsteroidal anti-inflammatory drugs, acetaminophen, and risk of skin cancer in the Nurses' Health Study. Cancer Causes Control 23(9):1451-1461.
20. Cahoon EK, Rajaraman P, Alexander BH, Doody MM, Linet MS, et al (2012) Use of nonsteroidal anti-inflammatory drugs and risk of basal cell carcinoma in the United States Radiologic Technologists study. Int J Cancer 130(12):2939-2948.
21. Clouser MC, Roe DJ, Foote JA, Harris RB (2009) Effect of non-steroidal antiinflammatory drugs on non-melanoma skin cancer incidence in the SKICAPAK trial. Pharmacoepidemiol Drug Saf 18(4):276-283.
22. Elmets CA, Viner JL, Pentland AP, Cantrell W, Lin HY, et al (2010) Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial. J Natl Cancer Inst 102(24):1835-1844.
23. Grau MV, Baron JA, Langholz B, Karagas M, Greenberg ER, et al (2006) Effect of NSAIDs on the recurrence of nonmelanoma skin cancer. Int J Cancer 119(3):682-686. (Pubitemid 43955724)
24. Torti DC, Christensen BC, Storm CA, Fortuny J, Perry AE, et al (2011) Analgesic and nonsteroidal anti-inflammatory use in relation to nonmelanoma skin cancer: a population-based case-control study. J Am Acad Dermatol 65(2):304-312.